51
TITLE: CLINICAL IMPACT OF IMMUNOGENICITY OF INFLIXIMAB, ADALIMUMAB AND ETANERCEPT: A SYSTEMATIC REVIEW OF THE LITERATURE WITH A META-ANALYSIS
AUTHORS: Garces, S; Demengeot, J; Benito Garcia, E;
PUBLISHED: 2013, SOURCE: ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 71, ISSUE: Suppl 3
INDEXED IN: WOS CrossRef: 8
IN MY: ORCID
52
TITLE: AB1297 Bridging ELISA as a secreening assay to monitor immunogenicity in routine clinical practice
AUTHORS: Garcês, S; Demengeot, J; Canas-da-Silva, J; Aarden, L;
PUBLISHED: 2013, SOURCE: Annals of the Rheumatic Diseases, VOLUME: 71, ISSUE: Suppl 3
INDEXED IN: CrossRef
IN MY: ORCID
53
TITLE: FRI0188 The impact of immunogenicity on drug safety profile
AUTHORS: Garcês, S; Freitas, J; Canas-Silva, J; Aarden, L; Demengeot, J;
PUBLISHED: 2013, SOURCE: Annals of the Rheumatic Diseases, VOLUME: 72, ISSUE: Suppl 3
INDEXED IN: CrossRef: 1
IN MY: ORCID
54
TITLE: FRI0189 A preliminary algorithm introducing immunogenicity assessment in the management of ra patients receiving biotechnological therapies
AUTHORS: Garcês, S; Antunes, M; Benito-Garcia, E; Canas-Silva, J; Aarden, L; Demengeot, J;
PUBLISHED: 2013, SOURCE: Annals of the Rheumatic Diseases, VOLUME: 72, ISSUE: Suppl 3
INDEXED IN: CrossRef: 1
IN MY: ORCID
55
TITLE: Recent thymic emigrants are the preferential precursors of regulatory T cells differentiated in the periphery
AUTHORS: Ricardo S Paiva; Andreia C Lino; Marie L Bergman; Íris Caramalho; Ana E Sousa; Santiago Zelenay; Jocelyne Demengeot;
PUBLISHED: 2013, SOURCE: Proceedings of the National Academy of Sciences
INDEXED IN: Handle
56
TITLE: The Immunogenicity of Infliximab, Adalimumab and Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Crohn's Disease and Ulcerative Colitis-a Quantitative and a Qualitative Review  Full Text
AUTHORS: Sandra Garces; Jocelyne Demengeot; Gj Wolbink; Aarden, L; Elizabeth Benito Garcia;
PUBLISHED: 2011, SOURCE: 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals in ARTHRITIS AND RHEUMATISM, VOLUME: 63, ISSUE: 10
INDEXED IN: WOS
57
TITLE: Bridging ELISA As a Screening Assay to Monitor Immunogenicity in Routine Clinical Practice  Full Text
AUTHORS: Sandra Garces; Jocelyne Demengeot; Canas C da Silva; Aarden, L;
PUBLISHED: 2011, SOURCE: 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals in ARTHRITIS AND RHEUMATISM, VOLUME: 63, ISSUE: 10
INDEXED IN: WOS
58
TITLE: Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients
AUTHORS: Nuno Costa; Ana E Pires; Ana M Gabriel; Luiz F Goulart; Clara Pereira; Barbara Leal; Ana C Queiros; Wahiba Chaara; Maria F Moraes-Fontes; Carlos Vasconcelos; Carlos Ferreira; Jorge Martins; Marina Bastos; Maria J Santos; Maria A Pereira; Berta Martins; Margarida Lima; Cristina João; Adrien Six; Jocelyne Demengeot; Constantin Fesel; ...More
PUBLISHED: 2011, SOURCE: Journal of Translational Medicine, VOLUME: 9, ISSUE: S2
INDEXED IN: CrossRef: 1 Handle
IN MY: ORCID
59
TITLE: Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease  Full Text
AUTHORS: Maria Francisca Moraes-Fontes; Manuel Rebelo; Íris Caramalho; Santiago Zelenay; Marie-Louise Bergman; António Coutinho; Jocelyne Demengeot;
PUBLISHED: 2009, SOURCE: Journal of Autoimmunity, VOLUME: 33, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
60
TITLE: Irf4 is a positional and functional candidate gene for the control of serum IgM levels in the mouse  Full Text
AUTHORS: Côrte-Real, J; Rodo, J; Almeida, P; Garcia, J; Coutinho, A; Demengeot, J; Penha-Gonçalves, C;
PUBLISHED: 2008, SOURCE: Genes and Immunity - Genes Immun, VOLUME: 10, ISSUE: 1
INDEXED IN: CrossRef
IN MY: ORCID
Page 6 of 8. Total results: 71.